Westfield Capital Management Company »

Arcutis Biotherapeutics shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2022-12-31 $10M 680k 14.80
2022-09-30 $9.0M 470k 19.11

More positions owned by Westfield Capital Management Company

Microsoft Corporation (MSFT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Builders FirstSource (BLDR)
Dex (DXCM)
UnitedHealth (UNH)
Servicenow (NOW)
Axon Enterprise (AXON)
Saia (SAIA)

View all positions for Westfield Capital Management Company

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics